{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:52:24Z","timestamp":1790887944921,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.lpm.2009.01.013","type":"journal-article","created":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T10:13:19Z","timestamp":1237371199000},"page":"1141-1163","source":"Crossref","is-referenced-by-count":20,"title":["Myopathies inflammatoires\u00a0: diagnostic et classifications"],"prefix":"10.1016","volume":"38","author":[{"given":"Dalia","family":"Dimitri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2009.01.013_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2009.01.013_bib2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2009.01.013_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.lpm.2009.01.013_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2009.01.013_bib5","series-title":"Myology, Basic and Clinical","first-page":"1321","article-title":"The Polymyositis and Dermatomyositis syndromes","author":"Engel","year":"2004"},{"key":"10.1016\/j.lpm.2009.01.013_bib6","first-page":"1656","article-title":"Polymyosite, dermatomyosite, myosite \u00e0 inclusions, aspects nosologiques","volume":"32","author":"Eymard","year":"2003","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2009.01.013_bib7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2009.01.013_bib8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0755-4982(06)74663-2","article-title":"Atteinte pulmonaire au cours des polymyosites et des dermatomyosites","volume":"35","author":"Marie","year":"2006","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2009.01.013_bib9","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2009.01.013_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2009.01.013_bib11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.50.3.764","article-title":"Paraneoplastic necrotizing myopathy: clinical and pathological features","volume":"50","author":"Levin","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.01.013_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2009.01.013_bib13","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1212\/WNL.57.11.2136","article-title":"Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients","volume":"57","author":"Gallardo","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.01.013_bib14","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.5858\/2007-131-1070-MHCCIA","article-title":"Major histocompatibility complex class I and II detection as a diagnostic tool in idiopathic inflammatory myopathies","volume":"131","author":"Jain","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.lpm.2009.01.013_bib15","first-page":"136","article-title":"Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies","volume":"75","author":"van der Pas","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2009.01.013_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","article-title":"A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies","volume":"54","author":"Gerami","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2009.01.013_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.11428","article-title":"Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells","volume":"50","author":"Page","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2009.01.013_bib18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1212\/WNL.61.3.288","article-title":"Unicorns, dragons, polymyositis, and other mythological beasts","volume":"61","author":"Amato","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.01.013_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archneur.61.1.132","article-title":"Polymyositis: an ongoing discussion about a disease entity","volume":"61","author":"Bronner","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2009.01.013_bib20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","article-title":"Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM","volume":"70","author":"Chahin","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.01.013_bib21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/bmj.329.7480.1464","article-title":"Polymyositis, invasion of non-necrotic muscle fibres, and the art of repetition","volume":"329","author":"Hengstman","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2009.01.013_bib22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","article-title":"Polymyositis: an overdiagnosed entity","volume":"61","author":"van der Meulen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.01.013_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mus.20649","article-title":"Myeloid dendritic cells in inclusion-body myositis and polymyositis","volume":"35","author":"Greenberg","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2009.01.013_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00002281-200211000-00004","article-title":"Inclusion body myositis","volume":"14","author":"Tawil","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.lpm.2009.01.013_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/brain\/112.3.727","article-title":"Inclusion body myositis. Observations in 40 patients","volume":"112","author":"Lotz","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2009.01.013_bib26","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1212\/01.wnl.0000192129.65677.87","article-title":"Inflammatory, immune, and viral aspects of inclusion-body myositis","volume":"66","author":"Dalakas","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.01.013_bib27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jnnp.70.5.706","article-title":"Anti-Jo-1 positive inclusion body myositis with a marked and sustained clinical improvement after oral prednisone","volume":"70","author":"Hengstman","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2009.01.013_bib28","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1212\/01.wnl.0000192260.33106.bb","article-title":"Inclusion-body myositis: clinical, diagnostic, and pathologic aspects","volume":"66","author":"Engel","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.01.013_bib29","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2009.01.013_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2009.01.013_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/WNL.63.2.402","article-title":"Polymyositis: an overdiagnosed entity","volume":"63","author":"Bradley","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.01.013_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/brain\/120.1.39","article-title":"Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy","volume":"120","author":"Blume","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2009.01.013_bib33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/WNL.57.3.548","article-title":"A prospective natural history study of inclusion body myositis: implications for clinical trials","volume":"57","author":"Rose","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.01.013_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.55.2.296","article-title":"Disease progression in sporadic inclusion body myositis: observations in 78 patients","volume":"55","author":"Peng","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.01.013_bib35","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0960-8966(02)00098-6","article-title":"Inclusion body myositis: morphological clues to correct diagnosis","volume":"12","author":"Dahlbom","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.lpm.2009.01.013_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.410390122","article-title":"Sporadic inclusion body myositis: counts of different types of abnormal fibers","volume":"39","author":"Pruitt","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2009.01.013_bib37","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00415-003-1027-y","article-title":"Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy","volume":"250","author":"Bronner","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2009.01.013_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF00328515","article-title":"Paraneoplastic necrotizing myopathy: a rare disorder to be differentiated from polymyositis","volume":"236","author":"Vosskamper","year":"1989","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2009.01.013_bib39","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1212\/WNL.41.6.936","article-title":"Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration","volume":"41","author":"Emslie-Smith","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.01.013_bib40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2009.01.013_bib41","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.1780330908","article-title":"Antibody to signal recognition particle in polymyositis","volume":"33","author":"Targoff","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2009.01.013_bib42","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","article-title":"Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2009.01.013_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":"Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2009.01.013_bib44","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2009.01.013_bib45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nmd.2006.03.002","article-title":"Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP)","volume":"16","author":"Arlet","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.lpm.2009.01.013_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mus.20693","article-title":"Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology","volume":"35","author":"Dimitri","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2009.01.013_bib47","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1212\/WNL.46.5.1448","article-title":"Necrotizing myopathy with pipestem capillaries and minimal cellular infiltration: a case associated with cutaneous signs of dermatomyositis","volume":"46","author":"Authier","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.01.013_bib48","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2009.01.013_bib49","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2009.01.013_bib50","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.2005.040717","article-title":"Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2009.01.013_bib51","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2009.01.013_bib52","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1002\/art.22862","article-title":"Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis","volume":"56","author":"Betteridge","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2009.01.013_bib53","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jnnp.68.4.472","article-title":"Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres","volume":"68","author":"Mozaffar","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2009.01.013_bib54","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/art.22860","article-title":"A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies","volume":"56","author":"Eloranta","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2009.01.013_bib55","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1422.029","article-title":"Systemic sclerosis-associated myopathy","volume":"1108","author":"Ranque","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.lpm.2009.01.013_bib56","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneur.64.8.1176","article-title":"Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes","volume":"64","author":"Nguyen","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2009.01.013_bib57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.nmd.2008.04.015","article-title":"Distal inflammatory myopathy: unusual presentation of polymyositis or new entity?","volume":"18","author":"Dimitri","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.lpm.2009.01.013_bib58","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000291619.17160.b8","article-title":"Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications","volume":"69","author":"Greenberg","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.01.013_bib59","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/brain\/awl020","article-title":"Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis","volume":"129","author":"Dimitri","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2009.01.013_bib60","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.23015","article-title":"Classification criteria for rheumatic diseases: why and how?","volume":"57","author":"Dougados","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2009.01.013_bib61","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/art.23018","article-title":"Classification criteria in rheumatic diseases: a review of methodologic properties","volume":"57","author":"Johnson","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2009.01.013_bib62","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.bor.0000179940.14109.50","article-title":"Autoimmune myositis: new concepts for disease initiation and propagation","volume":"17","author":"Casciola-Rosen","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.lpm.2009.01.013_bib63","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1002\/art.22790","article-title":"Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis","volume":"56","author":"Levine","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498209000888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498209000888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T10:05:38Z","timestamp":1633255538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498209000888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":63,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0755498209000888"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2009.01.013","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}